FdaApplication
NDA 202971
Identifiers
- fda_app_no: NDA202971
Properties
| Property | Value |
|---|---|
| applicant_name | OTSUKA PHARMACEUTICAL CO LTD |
| application_type | NDA |
| approval_date | 2013-02-28 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | 400MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | 300MG/VIAL | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | 400MG | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
| ABILIFY MAINTENA KIT | ARIPIPRAZOLE | 300MG | FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR |
4 products